Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Omada Health, Inc.OMDA · Entity 2364 | President | September 10, 2026 | September 14, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Omada Health, Inc.
Report date September 10, 2026 · Filed September 14, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 295,313 |
Ending reported balance
After 2026-09-10 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-09-10 · Sale · Disposed 3,636 · Balance 295,713 F1: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026. F2: This transaction was executed in multiple trades at prices ranging from $21.38 to $22.26. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Row 2 · 2026-09-10 · Sale · Disposed 400 · Balance 295,313 F1: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026. F3: This transaction was executed in multiple trades at prices ranging from $22.41 to $22.68. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
Filing footnotes · ownership attribution and instrument terms
F1: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026.
F2: This transaction was executed in multiple trades at prices ranging from $21.38 to $22.26. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3: This transaction was executed in multiple trades at prices ranging from $22.41 to $22.68. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 10, 2026 Filed Sep 14, 2026 21:11 UTC | Omada Health, Inc. OMDA · Entity 2364 | SaleCommon Stock | 400 | $22.53 | $9,013.00 |
DisclosureSEC source: 0001610717-26-000415 · form4.xml · nonDerivative · entry 2 Shao Wei-Li · CIK 0002069137 · President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 295,313 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026. F3 · price: This transaction was executed in multiple trades at prices ranging from $22.41 to $22.68. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| September 10, 2026 Filed Sep 14, 2026 21:11 UTC | Omada Health, Inc. OMDA · Entity 2364 | SaleCommon Stock | 3,636 | $21.78 | $79,193.17 |
DisclosureSEC source: 0001610717-26-000415 · form4.xml · nonDerivative · entry 1 Shao Wei-Li · CIK 0002069137 · President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 295,713 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026. F2 · price: This transaction was executed in multiple trades at prices ranging from $21.38 to $22.26. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| September 05, 2026 Filed Sep 9, 2026 20:57 UTC | Omada Health, Inc. OMDA · Entity 2364 | Tax withholdingCommon Stock | 1,843 | $22.77 | $41,965.11 |
DisclosureSEC source: 0001610717-26-000408 · form4.xml · nonDerivative · entry 1 Shao Wei-Li · CIK 0002069137 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 299,349 Read SEC document |
| September 01, 2026 Filed Sep 3, 2026 22:24 UTC | Omada Health, Inc. OMDA · Entity 2364 | Tax withholdingCommon Stock | 6,180 | $22.84 | $141,151.20 |
DisclosureSEC source: 0001610717-26-000400 · form4.xml · nonDerivative · entry 1 Shao Wei-Li · CIK 0002069137 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 301,192 Read SEC document |
| August 12, 2026 Filed Aug 12, 2026 20:50 UTC | Omada Health, Inc. OMDA · Entity 2364 | SaleCommon Stock | 8,866 | $25.02 | $221,798.06 |
DisclosureSEC source: 0001610717-26-000357 · form4.xml · nonDerivative · entry 1 Shao Wei-Li · CIK 0002069137 · President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 307,372 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026. Read SEC document |
| August 12, 2026 Filed Sep 4, 2026 20:14 UTC Amendment | Omada Health, Inc. OMDA · Entity 2364 | SaleCommon Stock | 9,418 | $25.02 | $235,607.28 |
DisclosureSEC source: 0001610717-26-000404 · form4a.xml · nonDerivative · entry 1 Shao Wei-Li · CIK 0002069137 · President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 307,372 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026. F2 · shares: This Form 4/A is being filed solely to correct the number of shares reported as sold pursuant to the Reporting Person's 10b5-1 plan on August 12, 2026. The amount of shares sold has been adjusted to reflect the addition of 552 shares that were inadvertently omitted from the original Form 4 filed with the U.S. Securities and Exchange Commission on August 12, 2026. Except as otherwise noted in this footnote, all other information disclosed in the Reporting Person's original Form 4 remains accurate. Read SEC document |
| June 12, 2026 Filed Jun 16, 2026 20:54 UTC | Omada Health, Inc. OMDA · Entity 2364 | SaleCommon Stock | 4,589 | $17.24 | $79,117.57 |
DisclosureSEC source: 0001610717-26-000224 · form4.xml · nonDerivative · entry 1 Shao Wei-Li · CIK 0002069137 · President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 316,238 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026. F2 · price: This transaction was executed in multiple trades at prices ranging from $17.10 to $17.54. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| June 12, 2026 Filed Jun 24, 2026 23:26 UTC Amendment | Omada Health, Inc. OMDA · Entity 2364 | SaleCommon Stock | 4,037 | $17.24 | $69,600.71 |
DisclosureSEC source: 0001610717-26-000295 · form4.xml · nonDerivative · entry 1 Shao Wei-Li · CIK 0002069137 · President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 316,790 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026. F2 · shares: This Form 4/A is being filed solely to correct the number of shares reported as sold on June 12, 2026, and the total number of shares beneficially owned. Due to an administrative error by the broker, the original Form 4 filing overstated the number of shares sold under the Reporting Person's 10b5-1 trading plan. This amendment corrects the error to reflect the actual number of shares sold and beneficially owned. F3 · price: This transaction was executed in multiple trades at prices ranging from $17.10 to $17.54. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| June 05, 2026 Filed Jun 9, 2026 20:41 UTC | Omada Health, Inc. OMDA · Entity 2364 | Tax withholdingCommon Stock | 1,843 | $17.93 | $33,044.99 |
DisclosureSEC source: 0001610717-26-000197 · form4.xml · nonDerivative · entry 1 Shao Wei-Li · CIK 0002069137 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 320,827 Read SEC document |
| June 01, 2026 Filed Jun 3, 2026 20:18 UTC | Omada Health, Inc. OMDA · Entity 2364 | Tax withholdingCommon Stock | 6,180 | $18.38 | $113,588.40 |
DisclosureSEC source: 0001610717-26-000181 · form4.xml · nonDerivative · entry 1 Shao Wei-Li · CIK 0002069137 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 322,670 Read SEC document |
| April 08, 2026 Filed Apr 10, 2026 20:05 UTC | Omada Health, Inc. OMDA · Entity 2364 | SaleCommon Stock | 2,829 | $12.71 | $35,945.84 |
DisclosureSEC source: 0001610717-26-000144 · form4.xml · nonDerivative · entry 1 Shao Wei-Li · CIK 0002069137 · President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 328,850 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by Wei-Li Shao on August 15, 2025. F2 · price: This transaction was executed in multiple trades at prices ranging from $12.51 to $13.05. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 05, 2026 Filed Mar 9, 2026 23:09 UTC | Omada Health, Inc. OMDA · Entity 2364 | Tax withholdingCommon Stock | 2,105 | $13.60 | $28,628.00 |
DisclosureSEC source: 0001610717-26-000090 · form4.xml · nonDerivative · entry 1 Shao Wei-Li · CIK 0002069137 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,974 Read SEC document |
| March 05, 2026 Filed Mar 13, 2026 23:00 UTC | Omada Health, Inc. OMDA · Entity 2364 | GrantCommon Stock | 264,705 | $0.00 | $0.00 |
DisclosureSEC source: 0001610717-26-000098 · form4.xml · nonDerivative · entry 1 Shao Wei-Li · CIK 0002069137 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 331,679 F1 · shares: Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 1/16th of the RSUs vest on each quarterly anniversary measured from March 1, 2026 (the "Vesting Commencement Date"), such that 100% of the RSUs will be fully vested on the fourth anniversary of the Vesting Commencement Date. Read SEC document |
| December 29, 2025 Filed Dec 30, 2025 21:42 UTC | Omada Health, Inc. OMDA · Entity 2364 | SaleCommon Stock | 5,618 | $16.13 | $90,645.87 |
DisclosureSEC source: 0001610717-25-000426 · form4.xml · nonDerivative · entry 1 Shao Wei-Li · CIK 0002069137 · President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 69,079 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by Wei-Li Shao on August 15, 2025. F2 · price: This transaction was executed in multiple trades at prices ranging from $15.87 to $16.44. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| December 05, 2025 Filed Dec 9, 2025 23:17 UTC | Omada Health, Inc. OMDA · Entity 2364 | Tax withholdingCommon Stock | 1,843 | $17.49 | $32,234.07 |
DisclosureSEC source: 0001610717-25-000415 · form4.xml · nonDerivative · entry 1 Shao Wei-Li · CIK 0002069137 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,697 Read SEC document |
| September 05, 2025 Filed Sep 9, 2025 21:04 UTC | Omada Health, Inc. OMDA · Entity 2364 | Tax withholdingCommon Stock | 2,407 | $24.28 | $58,441.96 |
DisclosureSEC source: 0001610717-25-000327 · form4.xml · nonDerivative · entry 1 Shao Wei-Li · CIK 0002069137 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 76,540 Read SEC document |
| June 05, 2025 Filed Jun 9, 2025 20:12 UTC | Omada Health, Inc. OMDA · Entity 2364 | GrantCommon Stock | 78,947 | $0.00 | $0.00 |
DisclosureSEC source: 0001610717-25-000177 · form4.xml · nonDerivative · entry 1 Shao Wei-Li · CIK 0002069137 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 78,947 F1 · shares: Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 1/16th of the RSUs vest on each quarterly anniversary measured from June 5, 2025 (the "Vesting Commencement Date"), such that 100% of the RSUs will be fully vested on the fourth anniversary of the Vesting Commencement Date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.